作者
Tone Enden, Leiv Sandvik, Nils-Einar Kløw, Geir Hafsahl, Pål Andre Holme, Lars Olaf Holmen, Waleed Ghanima, Anne Mette Njaastad, Gunnar Sandbæk, Carl-Erik Slagsvold, Per Morten Sandset
发表日期
2007/11/1
期刊
American heart journal
卷号
154
期号
5
页码范围
808-814
出版商
Mosby
简介
BACKGROUND
The conventional treatment of acute deep vein thrombosis (DVT) is anticoagulation and compression therapy, as recommended in the international guidelines. Anticoagulation prevents recurrent venous thrombosis, pulmonary embolism, and death. Compression therapy reduces the risk of developing long-term sequelae, that is, postthrombotic syndrome (PTS). Evaluation of systemic thrombolysis has shown effective thrombolysis and a likely reduction in PTS but at the cost of increased risk of bleeding complications. Catheter-directed thrombolysis (CDT) was introduced for rapid removal of thrombi and salvage of venous valves with less systemic thrombolytic effect, and is being offered to selected patients with iliofemoral DVT to prevent development of PTS. Case series have shown technical and thrombolytic success; however, no randomized studies have evaluated the long-term clinical effects of …
引用总数
200820092010201120122013201420152016201720182019202020212022202320244121716171561213714347242